Pre-Clinical RA - Clinical Trial Outcomes
Pivotal Trials in at-risk patients.
The risk of autoimmunity and rheumatic disease is heightened in women, especially with aging and certain populations
Distinguishing features between the 2021 ACR and 2022 EULAR RA treatment guidelines
Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).
Use this resource to keep track of your clinical trials and key information needed when communicating with patients about a drug study.
Comparison of COVID-19 deaths in the first 3 mos vs. over 30 mos since onset. USA leads the way.
This is part 1 of a 2 part slide series on how to make a MSK diagnosis 7 ways;
Identify “Red Flag” conditions (acute monarticular)
Arthritis by the Numbers (Most Common Stuff 1st )
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.